Literature DB >> 11756984

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Alexander W Friedrich1, Martina Bielaszewska, Wen-Lan Zhang, Matthias Pulz, Thorsten Kuczius, Andrea Ammon, Helge Karch.   

Abstract

Shiga toxin (Stx)-producing Escherichia coli (STEC) from patients with hemolytic-uremic syndrome (HUS), patients with diarrhea without HUS, or asymptomatic subjects were genotyped to assess associations between stx2 variants and clinical manifestations of infection. Neither stx2d nor stx2e was found in 268 STEC isolates from patients with HUS. Of 262 STEC isolates from patients with diarrhea, stx(2d) was found in 41 (15.6%; P<.000001), and stx2e was found in 12 (4.6%; P=.0004). The stx2c genotype frequency was similar among isolates from patients with HUS (3.7%) and diarrhea (5.0%). The frequencies of stx2c, stx2d, and stx2e among 96 STEC isolates from asymptomatic subjects were comparable to those among isolates from patients with diarrhea. None of the 626 STEC isolates contained stx2f. All stx2d-positive or stx2e-positive STEC isolates were eae negative and originated from subjects older than those with STEC isolates with stx2c. stx2c-positive STEC isolates can cause HUS, but the presence of stx2d or stx2e may predict a milder disease with a minimal risk of HUS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756984     DOI: 10.1086/338115

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  283 in total

1.  Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.

Authors:  Abhineet S Sheoran; Igor P Dmitriev; Elena A Kashentseva; Ocean Cohen; Jean Mukherjee; Michelle Debatis; Jonathan Shearer; Jacqueline M Tremblay; Gillian Beamer; David T Curiel; Charles B Shoemaker; Saul Tzipori
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak.

Authors:  Maite Muniesa; Mercè de Simon; Guillem Prats; Dolors Ferrer; Helena Pañella; Juan Jofre
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

3.  Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.

Authors:  Anne-Katharina Sonntag; Rita Prager; Martina Bielaszewska; Wenlan Zhang; Angelika Fruth; Helmut Tschäpe; Helge Karch
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

4.  Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups.

Authors:  Martina Bielaszewska; Marina Fell; Lilo Greune; Rita Prager; Angelika Fruth; Helmut Tschäpe; M Alexander Schmidt; Helge Karch
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis.

Authors:  Liesbet De Baets; Imme Van der Taelen; Marina De Filette; Denis Piérard; Lesley Allison; Henri De Greve; Jean-Pierre Hernalsteens; Hein Imberechts
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

6.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

7.  A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.

Authors:  Leticia V Bentancor; Marcos Bilen; Romina J Fernández Brando; María Victoria Ramos; Luis C S Ferreira; Pablo D Ghiringhelli; Marina S Palermo
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

Review 8.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Prevalence and characterization of shiga toxin-producing Escherichia coli in swine feces recovered in the National Animal Health Monitoring System's Swine 2000 study.

Authors:  Pina M Fratamico; Lori K Bagi; Eric J Bush; Barbara T Solow
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

10.  Shedding patterns of verocytotoxin-producing Escherichia coli strains in a cohort of calves and their dams on a Scottish beef farm.

Authors:  D J Shaw; C Jenkins; M C Pearce; T Cheasty; G J Gunn; G Dougan; H R Smith; M E J Woolhouse; G Frankel
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.